HPC
TEVA icon

Highland Peak Capital’s Teva Pharmaceuticals TEVA Stock Holding History

Highland Peak Capital’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.7M Buy
551,133
+129,980
+31% +$4.33M 5.43% 6
2026
Q1 		$12.7M Sell
421,153
-20,486
-5% -$659K 3.4% 9
2025
Q4 		$13.8M Sell
441,639
-132,146
-23% -$3.26M 4.54% 10
2025
Q3 		$11.6M Sell
573,785
-81,440
-12% -$1.43M 3.8% 12
2025
Q2 		$11M Buy
+655,225
New +$10.6M 4.11% 9

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Highland Peak Capital's TEVA Position: Q2 2026 in Review

Highland Peak Capital increased its Teva Pharmaceuticals (TEVA) stake by 31% in Q2 2026, buying an estimated $4.33M and bringing the position to 551,133 shares worth $18.7M. The position accounts for 5.43% of the portfolio, ranked #6.

Highland Peak Capital first reported a position in TEVA in Q2 2025 and has held it in 5 quarters since. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Highland Peak Capital held 551,133 shares of Teva Pharmaceuticals worth $18.7M as of Q2 2026.
  • Highland Peak Capital bought 129,980 Teva Pharmaceuticals shares in Q2 2026, an estimated $4.33M.
  • Teva Pharmaceuticals made up 5.43% of Highland Peak Capital's portfolio in Q2 2026, its #6 holding.
  • Highland Peak Capital first reported a position in Teva Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Highland Peak Capital's 13F filing for Q2 2026, filed 12 Aug 2026.